Primary biliary cirrhosis associated with systemic sclerosis: diagnostic and clinical challenges.

scientific article published on 6 December 2011

Primary biliary cirrhosis associated with systemic sclerosis: diagnostic and clinical challenges. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1155/2011/976427
P932PMC publication ID3236477
P698PubMed publication ID22187566
P5875ResearchGate publication ID51880167

P50authorAndrew Kenneth BurroughsQ18385218
Dimitrios P. BogdanosQ48362185
P2093author name stringDaniel S Smyk
Eirini I Rigopoulou
Maria G Mytilinaiou
Cristina Rigamonti
P2860cites workRheumatic disorders in primary biliary cirrhosisQ24514482
Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variantsQ24633806
[Association of extrahepatic autoimmune diseases in primary biliary cirrhosis--clinical statistics and analyses of Japanese and non-Japanese cases]Q77490583
Bosentan therapy for pulmonary arterial hypertensionQ77801473
Association of clonally expanded T cells with the syndrome of primary biliary cirrhosis and limited sclerodermaQ77807929
Systemic scleroderma, A clinical study of 727 casesQ79087145
Does cross-reactivity between mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn's disease?Q79871772
Origin of cross-reactive autoimmunity in primary biliary cirrhosisQ79910285
HLA class II alleles, genotypes, haplotypes, and amino acids in primary biliary cirrhosis: a large-scale studyQ80188338
Disease-specific autoantibodies in patients with acute liver failure: the King's College London ExperienceQ80788168
Primary biliary cirrhosisQ81246142
Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosisQ81402950
Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosisQ84227289
Primary biliary cirrhosisQ84230884
Primary biliary cirrhosis-specific autoantibodies in patients with systemic sclerosisQ84234141
Association of STAT4 polymorphism with systemic sclerosis in a Japanese populationQ84236673
Asymptomatic primary biliary cirrhosis. A progress report on long-term follow-up and natural historyQ93573634
HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseasesQ24679388
The peculiar autoimmunity of primary biliary cirrhosisQ28144212
A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study GroupQ28243457
Disease-specific cross-reactivity between mimicking peptides of heat shock protein of Mycobacterium gordonae and dominant epitope of E2 subunit of pyruvate dehydrogenase is common in Spanish but not British patients with primary biliary cirrhosisQ28259544
A sensitive bead assay for antimitochondrial antibodies: Chipping away at AMA-negative primary biliary cirrhosisQ28290430
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosisQ28943317
Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosisQ29417041
Antimitochondrial antibody negative primary biliary cirrhosis in Japan: utilization of clinical data when patients applied to receive public financial aid.Q31027142
Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodiesQ33553751
Anticentromere antibody in primary biliary cirrhosisQ33553886
Reactivity of primary biliary cirrhosis sera with Escherichia coli dihydrolipoamide acetyltransferase (E2p): characterization of the main immunogenic regionQ33596407
Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populationsQ33653276
Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysisQ33745849
Autoimmunity and environment: am I at risk?Q33825348
Primary biliary cirrhosis once rare, now common in the United Kingdom?Q33869156
Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patientsQ33912324
Association of interleukin 23 receptor polymorphisms with anti-topoisomerase-I positivity and pulmonary hypertension in systemic sclerosisQ33955502
Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis.Q33965981
Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controlsQ34046875
Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosisQ34081935
Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosisQ34087671
Primary biliary cirrhosis: a 2010 updateQ34106999
Positive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis?Q34190802
Patterns of autoimmunity in primary biliary cirrhosis patients and their families: a population-based cohort study.Q34328076
Polymorphisms in TBX21 and STAT4 increase the risk of systemic sclerosis: evidence of possible gene-gene interaction and alterations in Th1/Th2 cytokinesQ34385555
Antinuclear antibodies in primary biliary cirrhosisQ34448645
Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patientsQ34462959
Bacteriuria and primary biliary cirrhosisQ34525085
Pediatric autoimmune liver diseases: the molecular basis of humoral and cellular immunityQ34567100
Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosisQ34594429
Pathogenesis of primary biliary cirrhosisQ34653850
Survival following the onset of scleroderma: results from a retrospective inception cohort study of the UK patient population.Q50987542
Mortality in systemic sclerosis: a comparison with the general population.Q51037502
Prevalence and incidence of primary biliary cirrhosis are increasing in Finland.Q51108387
Risk factors for primary biliary cirrhosis in a cohort of patients from the united statesQ44933098
Epidemiology of primary biliary cirrhosis in Victoria, Australia: high prevalence in migrant populationsQ45010914
Extensive homology between the major immunodominant mitochondrial antigen in primary biliary cirrhosis and Helicobacter pylori does not lead to immunological cross-reactivity.Q45129507
Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 yearsQ45161999
Primary biliary cirrhosis and the CREST syndrome: a report of 22 cases.Q45261791
New ELISA for detecting primary biliary cirrhosis-specific antimitochondrial antibodies.Q46098794
Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosisQ46408092
Clinical and serological heterogeneity in patients with anticentromere antibodies.Q46632886
Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environmentQ46795010
Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese populationQ47696929
Primary biliary cirrhosis specific antinuclear antibodies in patients from Spain.Q47751089
The Hsp60 protein of Helicobacter pylori: structure and immune response in patients with gastroduodenal diseasesQ48109102
Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controlsQ49051672
The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosisQ49110706
Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: a population-based study.Q51137626
A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosisQ51586165
The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype.Q51768945
Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC.Q53711274
SclerodermaQ54165664
Association of HLA class II genes with systemic sclerosis in Spanish patients.Q54456368
Precipitating autoantibodies to mitochondrial proteins in progressive systemic sclerosis.Q54467810
Influence of ursodeoxycholic acid on the mortality and malignancy associated with primary biliary cirrhosis: a population-based cohort study.Q55044287
EASL Clinical Practice Guidelines: management of cholestatic liver diseases.Q55051951
Scleroderma and primary biliary cirrhosisQ56008640
Polyautoimmunity and familial autoimmunity in systemic sclerosisQ56452712
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) databaseQ56974596
Key Residues of a Major Cytochrome P4502D6 Epitope Are Located on the Surface of the MoleculeQ57062000
Association between theIRF5rs2004640 functional polymorphism and systemic sclerosis: A new perspective for pulmonary fibrosisQ57613023
BANK1is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects withIRF5andSTAT4Q57613025
STAT4is a genetic risk factor for systemic sclerosis having additive effects withIRF5on disease susceptibility and related pulmonary fibrosisQ57613049
Morphologic capillary changes and manifestations of connective tissue diseases in patients with primary biliary cirrhosisQ58865472
PBC Screen: An IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosisQ59384457
Anti-Centromere Antibody and CREST Syndrome in Patients with Primary Biliary CirrhosisQ67468697
A case of rheumatoid arthritis associated with progressive systemic sclerosis and primary biliary cirrhosis in the presence of various autoantibodiesQ67939351
High prevalence of autoimmune liver disease in patients with multiple nuclear dot, anti-centromere, and mitotic spindle antibodiesQ67979771
[Primary biliary cirrhosis and scleroderma]Q68529722
Primary biliary cirrhosis and rheumatic diseases: a clinical, immunological and immunogenetical studyQ68801707
The Presentation and Diagnosis of 100 Patients with Primary Biliary CirrhosisQ69302463
[Primary biliary cirrhosis and scleroderma: long-term benign course of a complex autoimmune disease]Q70093262
Anticentromere antibody. Clinical Correlations and association with favorable prognosis in patients with scleroderma variantsQ70240365
The anticentromere antibody: disease specificity and clinical significanceQ70383558
Anticentromere antibodies in primary biliary cirrhosisQ70440116
Primary biliary cirrhosis associated with sclerodermaQ70449670
Anticentromere antibody and primary pulmonary hypertensionQ71446708
The Association of Primary Biliary Cirrhosis and Systemic Sclerosis is not Accounted for by Cross Reactivity Between Mitochondrial and Centromere AntigensQ71647778
Primary biliary cirrhosis with scleroderma, Raynaud's phenomenon and telangiectasia. New syndromeQ71781429
Autoimmune associations in primary biliary cirrhosisQ71859621
Ursodeoxycholic acid in the treatment of primary biliary cirrhosisQ72401649
Primary biliary cirrhosis: survival of a large cohort of symptomatic and asymptomatic patients followed for 24 yearsQ72727069
Anticentromere antibodies (ACA): clinical distribution and disease specificityQ72792454
Positive markers in AMA-negative PBCQ73012261
Detection of Helicobacter in the liver of patients with chronic cholestatic liver diseasesQ73494945
Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the LiverQ73715566
Primary biliary cirrhosisQ73732260
Mimicry peptides of human PDC-E2 163-176 peptide, the immunodominant T-cell epitope of primary biliary cirrhosisQ73825688
Clinical and immunological characterization of patients with systemic sclerosis overlapping primary biliary cirrhosis: a comparison with patients with systemic sclerosis aloneQ74576861
[Coincidence of scleroderma and primary biliary cirrhosis. Results of a systematic study of a dermatologic patient sample]Q74710284
Unusual suspects in primary biliary cirrhosisQ75369505
CHRONIC DISEASE OF THE LIVER ASSOCIATED WITH SYSTEMIC SCLERODERMAQ76677074
[Reynolds syndrome: the combination of scleroderma and primary biliary cirrhosis. Case report]Q77072146
Immunological features of patients with primary biliary cirrhosis (PBC) overlapping systemic sclerosis: a comparison with patients with PBC aloneQ77483123
Infections in systemic connective tissue diseases: systemic lupus erythematosus, scleroderma, and polymyositis/dermatomyositisQ35084903
Serum antibodies to Helicobacter hepaticus and Helicobacter pylori in patients with chronic liver diseaseQ35359468
Rheumatic disorders and primary biliary cirrhosis: an appraisal of 170 Italian patientsQ35549891
Hepatic manifestations of autoimmune rheumatic diseasesQ35553844
Antimitochondrial and other autoantibodiesQ35573899
Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohortQ35596580
Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosisQ35760198
Correlation of Chlamydia pneumoniae infection with primary biliary cirrhosisQ35851191
Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasisQ36495172
Is there a relation between Chlamydia infection and primary biliary cirrhosis?Q36792963
The causes of primary biliary cirrhosis: Convenient and inconvenient truthsQ37039889
Bacteria and primary biliary cirrhosis.Q37170862
Systemic sclerosis and infectionsQ37244868
European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature researchQ37310658
PBC triggers in water reservoirs, coal mining areas and waste disposal sites: from Newcastle to New York.Q37328942
EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).Q37369608
Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosisQ37388003
Primary biliary cirrhosis: paradigm or paradox for autoimmunityQ37637964
The genetics of scleroderma (systemic sclerosis).Q37678890
Do infections facilitate the emergence of systemic sclerosis?Q37791690
Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research GroupQ37809920
Disease-specific autoantibodies in primary biliary cirrhosis.Q37824020
The role of E. coli infection in the pathogenesis of primary biliary cirrhosis.Q37836241
Primary biliary cirrhosis: an infectious disease caused by Chlamydia pneumoniae?Q37867201
Vascular impairment in patients with primary biliary cirrhosis.Q39422924
Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma)Q39473931
Autoantibodies in systemic sclerosisQ39726030
Anticentromere antibody--clinical associations. A study of 44 patientsQ40435776
Epidemiology and natural history of primary biliary cirrhosis in a US communityQ40735092
Natural history of early primary biliary cirrhosisQ41234807
Nuclear envelope protein autoantibodies in primary biliary cirrhosisQ41412977
Test performance in systemic sclerosis: anti-centromere and anti-Scl-70 antibodiesQ41605342
BANK1 functional variants are associated with susceptibility to diffuse systemic sclerosis in CaucasiansQ41886328
Symptom development and prognosis in primary biliary cirrhosis: a study in two centersQ41955973
Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodiesQ42603143
The independent effects of fatigue and UDCA therapy on mortality in primary biliary cirrhosis: Results of a 9year follow-upQ42923603
Susceptibility to thyroid disorders in hepatitis C.Q42993073
Chlamydia pneumoniae infection is an unlikely cause of primary biliary cirrhosisQ43419797
Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic AcidQ43483632
Reynolds syndrome--a rare combination of 2 autoimmune diseasesQ43878632
Increased prevalence of seropositivity for non-gastric Helicobacter species in patients with autoimmune liver diseaseQ44364574
Is prevalence of PBC underestimated in patients with systemic sclerosis?Q44765533
Reactivity of anti-mitochondrial antibodies in primary biliary cirrhosis and systemic sclerosisQ44809199
P275copyright licenseCreative Commons Attribution 3.0 UnportedQ14947546
P6216copyright statuscopyrightedQ50423863
P921main subjectprimary biliary cholangitisQ1072420
P304page(s)976427
P577publication date2011-12-06
P1433published inInternational journal of rheumatologyQ26853833
P1476titlePrimary biliary cirrhosis associated with systemic sclerosis: diagnostic and clinical challenges
P478volume2011

Reverse relations

cites work (P2860)
Q26741006Capillaroscopy - a role in modern rheumatology
Q92003565From pruritus to CREST syndrome in a middle aged woman
Q90601482Gastrointestinal Manifestations of Systemic Sclerosis
Q26796362Genetics of systemic sclerosis: recent advances
Q38063171Potential Roles for Infectious Agents in the Pathophysiology of Primary Biliary Cirrhosis: What's New?
Q36369284Rheumatoid arthritis and primary biliary cirrhosis: cause, consequence, or coincidence?
Q36014535Sex differences associated with primary biliary cirrhosis.
Q36361121TRAF1 gene polymorphism correlates with the titre of Gp210 antibody in patients with primary biliary cirrhosis
Q59130562The Geoepidemiology of Autoimmune Liver Disease
Q56378345The Role of Invariant NKT in Autoimmune Liver Disease: Can Vitamin D Act as an Immunomodulator?
Q36417949Tuberculosis is not a risk factor for primary biliary cirrhosis: a review of the literature

Search more.